Literature DB >> 28447405

High mortality from Guillain-Barré syndrome in Bangladesh.

Tanveen Ishaque1,2, Mohammad B Islam1,3, Gulshan Ara1, Hubert P Endtz1,3,4, Quazi D Mohammad5, Bart C Jacobs6,7, Zhahirul Islam1.   

Abstract

Although Guillain-Barré syndrome (GBS) has higher incidence and poor outcome in Bangladesh, mortality from GBS in Bangladesh has never been explored before. We sought to explore the frequency, timing, and risk factors for deaths from GBS in Bangladesh. We conducted a prospective study on 407 GBS patients who were admitted to Dhaka Medical College Hospital, Dhaka, Bangladesh from 2010 to 2013. We compared deceased and alive patients to identify risk factors. Cox regression model was used to adjust for confounders. Of the 407 GBS patients, 50 (12%) died, with the median time interval between the onset of weakness and death of 18 days. Among the fatal cases, 24 (48%) were ≥40 years, 36 (72%) had a Medical Research Council sum score ≤20 at entry, 33 (66%) had a progressive phase <8 days, and 27 (54%) required ventilation support. Ten patients (20%) died due to unavailability of ventilator. The strongest risk factor for deaths was lack of ventilator support when it was required (HR: 11.9; 95% confidence interval [CI]: 4.6-30.7). Other risk factors for death included age ≥40 years (HR: 5.9; 95% CI: 2.1-16.7), mechanical ventilation (HR: 2.3; 95% CI: 1.02-5.2), longer progressive phase (>8 days) (HR: 2.06; 95% CI: 1.1-3.8), autonomic dysfunction (HR: 1.9; 95% CI: 1.05-3.6), and bulbar nerve involvement (HR: 5.4; 95% CI: 1.5-19.2). In Bangladesh, GBS is associated with higher mortality rates, which is related to lack of ventilator support, disease severity, longer progressive phase of the disease, autonomic dysfunction, and involvement of the bulbar nerves.
© 2017 Peripheral Nerve Society.

Entities:  

Keywords:  Bangladesh; Guillain-Barré syndrome; autonomic dysfunction; mechanical ventilation; mortality

Mesh:

Year:  2017        PMID: 28447405     DOI: 10.1111/jns.12215

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  9 in total

1.  Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.

Authors:  Cheng-Yin Tan; Nortina Shahrizaila; Kee-Ying Yeoh; Khean-Jin Goh; Maw-Pin Tan
Journal:  Clin Auton Res       Date:  2018-04-13       Impact factor: 4.435

2.  FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.

Authors:  Zhahirul Islam; Israt Jahan; Rijwan U Ahammad; Mohammad Shahnaij; Shamsun Nahar; Quazi D Mohammad
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

3.  Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study.

Authors:  Badrul Islam; Zhahirul Islam; Shafiqur Rahman; Hubert P Endtz; Margreet C Vos; Mathieu van der Jagt; Peter A van Doorn; Bart C Jacobs; Quazi Deen Mohammad
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692

4.  Risk factors for respiratory failure in Guillain-Barré syndrome in Bangladesh: a prospective study.

Authors:  Zhahirul Islam; Nowshin Papri; Gulshan Ara; Tanveen Ishaque; Arafat U Alam; Israt Jahan; Badrul Islam; Quazi D Mohammad
Journal:  Ann Clin Transl Neurol       Date:  2019-01-07       Impact factor: 4.511

5.  Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study.

Authors:  Safiyyah Asiri; Waleed A Altwaijri; Duaa Ba-Armah; Ahmed Al Rumayyan; Muhammad T Alrifai; Mahmoud Salam; Adel F Almutairi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-01       Impact factor: 2.570

6.  Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.

Authors:  Ariadna Capasso; Danielle C Ompad; Dorice L Vieira; Annelies Wilder-Smith; Yesim Tozan
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

Review 7.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

Review 8.  Guillain-Barré syndrome in low-income and middle-income countries: challenges and prospects.

Authors:  Nowshin Papri; Zhahirul Islam; Sonja E Leonhard; Quazi D Mohammad; Hubert P Endtz; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2021-03-01       Impact factor: 42.937

9.  Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh.

Authors:  Nowshin Papri; Alex Y Doets; Quazi D Mohammad; Hubert P Endtz; Hester F Lingsma; Bart C Jacobs; Zhahirul Islam
Journal:  Ann Clin Transl Neurol       Date:  2022-07-30       Impact factor: 5.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.